Madrigal Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Madrigal Pharmaceuticals, Inc.‘s stocks are currently a part of 132 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 12.14M shares of Madrigal Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 1.59% or 190.25K shares more. As for the holding position changes, 33.33% (44) of current hedge fund investors increased the number of shares held, 33.33% (44) of current holders sold a part of the shares held, and 19.7% (26) closed the holdings completely. 18 hedge funds are new holders of Madrigal Pharmaceuticals, Inc. stock in Q1 2022, it is 13.64% of total holders.
Hedge funds holding Madrigal Pharmaceuticals (Q2 2017 – Q1 2022)
| Q2 2017 | 39 |
|---|---|
| Q3 2017 | 50 |
| Q4 2017 | 90 |
| Q1 2018 | 98 |
| Q2 2018 | 147 |
| Q3 2018 | 153 |
| Q4 2018 | 133 |
| Q1 2019 | 134 |
| Q2 2019 | 116 |
| Q3 2019 | 111 |
| Q4 2019 | 119 |
| Q1 2020 | 107 |
| Q2 2020 | 125 |
| Q3 2020 | 124 |
| Q4 2020 | 132 |
| Q1 2021 | 134 |
| Q2 2021 | 145 |
| Q3 2021 | 129 |
| Q4 2021 | 141 |
| Q1 2022 | 132 |
Hedge funds changes in Madrigal Pharmaceuticals positions (Q2 2017 – Q1 2022)
| Q2 2017 | 20 | 10 | 3 | 8 | -2 |
|---|---|---|---|---|---|
| Q3 2017 | 16 | 15 | 8 | 4 | 7 |
| Q4 2017 | 48 | 26 | 10 | 8 | -2 |
| Q1 2018 | 28 | 38 | 24 | 19 | -11 |
| Q2 2018 | 63 | 47 | 34 | 13 | -10 |
| Q3 2018 | 36 | 59 | 44 | 29 | -15 |
| Q4 2018 | 21 | 53 | 46 | 41 | -28 |
| Q1 2019 | 24 | 49 | 31 | 22 | 8 |
| Q2 2019 | 12 | 55 | 24 | 27 | -2 |
| Q3 2019 | 14 | 48 | 27 | 18 | 4 |
| Q4 2019 | 24 | 43 | 34 | 16 | 2 |
| Q1 2020 | 15 | 46 | 27 | 25 | -6 |
| Q2 2020 | 28 | 45 | 36 | 10 | 6 |
| Q3 2020 | 12 | 41 | 45 | 12 | 14 |
| Q4 2020 | 20 | 46 | 41 | 12 | 13 |
| Q1 2021 | 18 | 52 | 37 | 15 | 12 |
| Q2 2021 | 28 | 60 | 34 | 16 | 7 |
| Q3 2021 | 9 | 47 | 40 | 25 | 8 |
| Q4 2021 | 29 | 42 | 40 | 16 | 14 |
| Q1 2022 | 18 | 44 | 44 | 26 | 0 |
Hedge funds changes in Madrigal Pharmaceuticals stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 55,397,000 | 8,647,000 |
| Q3 2018 | 101,165,000 | 24,480,000 |
| Q4 2018 | 88,518,000 | 17,035,000 |
| Q1 2019 | 79,351,000 | 34,290,000 |
| Q2 2019 | 30,181,000 | 35,129,000 |
| Q3 2019 | 6,993,000 | 14,220,000 |
| Q4 2019 | 2,314,000 | 27,985,000 |
| Q1 2020 | 1,713,000 | 9,114,000 |
| Q2 2020 | 27,069,000 | 17,069,000 |
| Q3 2020 | 29,657,000 | 19,168,000 |
| Q4 2020 | 9,070,000 | 4,182,000 |
| Q1 2021 | 8,076,000 | 3,413,000 |
| Q2 2021 | 5,621,000 | 4,909,000 |
| Q3 2021 | 9,870,000 | 5,909,000 |
| Q4 2021 | 9,964,000 | 8,749,000 |
| Q1 2022 | 9,341,000 | 15,727,000 |